Through advancements in science, medicine, and genomics, we aim
to improve the lives of patients who suffer from cancer and other
Diverse Biotech is a biopharmaceutical research company, focused on new medical discoveries and the development of new molecules for the treatment of disease. Commercialization path of these new discoveries include;
Diverse DNA is a wholly owned subsidiary that is at the forefront of early cancer detection and transforming patient care through advanced personalized genomic testing so patients can make better lifestyle decisions.
Each day, countless lives around the world are devastated by cancer diagnoses. We want to make a difference and develop novel treatments that save lives and give people hope.